Recombinant B7-H3 (Enoblituzumab Biosimilar) antibody
The Humanized Chimeric anti-B7-H3 (Enoblituzumab Biosimilar) antibody (ABIN7597664) specifically detects B7-H3 (Enoblituzumab Biosimilar).
The antibody is reactive with Human samples.
Catalog No. ABIN7597664
$401.14
Plus shipping costs $50.00, if applicable $20.00 dry ice
Shipping to:
United States
Delivery in 12 to 15 Business Days
Quick Overview for Recombinant B7-H3 (Enoblituzumab Biosimilar) antibody (ABIN7597664)
Target
B7-H3 (Enoblituzumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Chimeric
Conjugate
This B7-H3 (Enoblituzumab Biosimilar) antibody is un-conjugated
Application
Please inquire
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Research Grade Enoblituzumab Biosimilar Antibody
-
Specificity
- CD276, B7-H3, Costimulatory molecule, B7H3, 4Ig-B7-H3, B7 homolog 3, CD276 antigen
-
Purification
- Protein A or G purified from cell culture supernatant.
-
Purity
- >95 % by SDS-PAGE.
-
Isotype
- IgG1 kappa
-
-
anti-B7-H3 (Enoblituzumab Biosimilar) antibody
Research Grade Reactivity: Human ELISA, FACS Host: Humanized Monoclonal unconjugated Recombinant Antibody
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 2.04 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Expiry Date
- 12 months
-
-
- B7-H3 (Enoblituzumab Biosimilar)
-
Alternative Name
- Enoblituzumab Biosimilar
-
Target Type
- Biosimilar
-
Background
- CD276, B7-H3, Costimulatory molecule, B7H3, 4Ig-B7-H3, B7 homolog 3, CD276 antigen
-
UniProt
- Q5ZPR3
-
CAS-No
- 1353485-38-7
Target
-
You are here:
